STATIN-FIBRATE REPORT: Focus on Safety

Monitor INR prior to commencing a statin, fibrate or Omacor and around the time of dose adjustments. If prescribing drugs which may also induce or inhibit cytochrome P450 3A4 increased INR monitoring or statin withdrawal is needed. References. 1 Statin induced myopathy (Clinical Review). BMJ 2008; 337: 1159-1162 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download